2-240783028-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001244008.2(KIF1A):c.864+16C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.211 in 1,604,656 control chromosomes in the GnomAD database, including 39,854 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.27 ( 6631 hom., cov: 34)
Exomes 𝑓: 0.21 ( 33223 hom. )
Consequence
KIF1A
NM_001244008.2 intron
NM_001244008.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.763
Publications
9 publications found
Genes affected
KIF1A (HGNC:888): (kinesin family member 1A) The protein encoded by this gene is a member of the kinesin family and functions as an anterograde motor protein that transports membranous organelles along axonal microtubules. Mutations at this locus have been associated with spastic paraplegia-30 and hereditary sensory neuropathy IIC. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Apr 2012]
KIF1A Gene-Disease associations (from GenCC):
- intellectual disability, autosomal dominant 9Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- syndromic intellectual disabilityInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- neuropathy, hereditary sensory, type 2CInheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- hereditary spastic paraplegia 30Inheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
- autosomal dominant non-syndromic intellectual disabilityInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- PEHO syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary sensory and autonomic neuropathy type 2Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (REVEL=0.014).
BP6
Variant 2-240783028-G-A is Benign according to our data. Variant chr2-240783028-G-A is described in ClinVar as [Benign]. Clinvar id is 283505.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.439 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.272 AC: 41401AN: 152006Hom.: 6623 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
41401
AN:
152006
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.219 AC: 54419AN: 248348 AF XY: 0.207 show subpopulations
GnomAD2 exomes
AF:
AC:
54419
AN:
248348
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.205 AC: 297905AN: 1452532Hom.: 33223 Cov.: 31 AF XY: 0.200 AC XY: 144972AN XY: 723286 show subpopulations
GnomAD4 exome
AF:
AC:
297905
AN:
1452532
Hom.:
Cov.:
31
AF XY:
AC XY:
144972
AN XY:
723286
show subpopulations
African (AFR)
AF:
AC:
15088
AN:
33268
American (AMR)
AF:
AC:
11934
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
AC:
5147
AN:
26082
East Asian (EAS)
AF:
AC:
14809
AN:
39634
South Asian (SAS)
AF:
AC:
9236
AN:
86102
European-Finnish (FIN)
AF:
AC:
9035
AN:
52972
Middle Eastern (MID)
AF:
AC:
1187
AN:
5754
European-Non Finnish (NFE)
AF:
AC:
218513
AN:
1103902
Other (OTH)
AF:
AC:
12956
AN:
60114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
10700
21399
32099
42798
53498
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.272 AC: 41421AN: 152124Hom.: 6631 Cov.: 34 AF XY: 0.268 AC XY: 19904AN XY: 74368 show subpopulations
GnomAD4 genome
AF:
AC:
41421
AN:
152124
Hom.:
Cov.:
34
AF XY:
AC XY:
19904
AN XY:
74368
show subpopulations
African (AFR)
AF:
AC:
18442
AN:
41490
American (AMR)
AF:
AC:
4146
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
721
AN:
3470
East Asian (EAS)
AF:
AC:
1744
AN:
5152
South Asian (SAS)
AF:
AC:
514
AN:
4812
European-Finnish (FIN)
AF:
AC:
1688
AN:
10616
Middle Eastern (MID)
AF:
AC:
67
AN:
294
European-Non Finnish (NFE)
AF:
AC:
13451
AN:
67976
Other (OTH)
AF:
AC:
512
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1471
2943
4414
5886
7357
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
760
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Sep 22, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Neuropathy, hereditary sensory, type 2C;C5235139:Hereditary spastic paraplegia 30;C5393830:Intellectual disability, autosomal dominant 9 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.